RÊVE Consortium
REVolutionner la DrépanocytosE
Pensé comme un projet à forte portée internationale, REVE vise à ouvrir une nouvelle étape dans la prise en charge de la drépanocytose.
Support RED
Transforming the lives of people affected by the world’s most common inherited blood disorder is within our reach.
WHAT IF WE COULD RADICALLY CHANGE THE LIVES OF MILLIONS OF PATIENTS WITH SICKLE CELL DISEASE?
The REVE project (REVolutionner la DrépanocytosE) aims to develop a healthcare model that is better coordinated, more practical and more focused on patients.
Sickle cell disease is still under-diagnosed and not always properly understood or managed. REVE therefore works on care, research, innovation and training at the same time. It brings together doctors, researchers, industry partners and patient organisations so that progress can reach patients more quickly.
At the heard of REVE: innovative and practical solutions
- smart digital tools for real-time patient monitoring,
- cutting-edge technologies to anticipate complications,
- expert support to speed up clinical trials,
- and a training platform to disseminate knowledge on a large scale.
The impact is significant: better prevention, better treatment, and a better quality of life with the condition. REVE aims to reduce mortality, improve quality of life and make healthcare systems more efficient and equitable.
REVE is a long-term international programme intended to improve the lives of people with sickle cell disease.
Support us to give them a better future
Every donation funds direct action on the ground: equipping a screening centre, training a doctor or developing information tools for patients. Sickle cell disease affects millions of people but remains severely underfunded. Your support changes lives.
Our projects
We run practical programmes to support earlier diagnosis, better care and wider access to information. Our projects cover research, prevention, therapeutic patient education and access to healthcare in the regions most affected by sickle cell disease.
Our partners
RED is supported by a strong network of institutional, scientific and community partners. Within the RÊVE consortium and beyond, we combine our strengths to accelerate research and improve care wherever sickle cell disease occurs.
